IndraLab

Statements


EDN1 activates EGFR. 10 / 35
| 1 30 4

sparser
"The EGFR is activated by endothelin-1 in asthmatic airway smooth muscle cells and is involved in airway remodeling in asthma ( xref )."

reach
"ET-1 addition to ovarian cancer cells increased EGFR transactivation and ovarian cancer cellular proliferation which was inhibited by ZD4054 or gefitinib [XREF_BIBR]."

reach
"Among downstream events after endothelin receptor activation, ET-1 causes EGF receptor transactivation, which is partly responsible for MAPK activation [XREF_BIBR, XREF_BIBR]."

trips
"ZD4054 was able to reduce the ET-1-induced EGFR transactivation."

sparser
"Activation of MAPK members was detected following stimulation of cells with transforming growth factor α (TNFα) [12] , as well as through epidermal growth factor receptor activation by EGF (13,14) o[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"EGFR transactivation caused by addition of ET-1 is dependent on generation of ROS, which may reduce essential disulfide bonds impairing phosphotyrosine."

reach
"Although the ET (A) receptor subtype is not involved in the early activation of MMPs in type 2 diabetes, ET-1 contributes to transactivation of growth promoting and profibrotic EGFR."

reach
"In HEY and OVCA 433 ovarian carcinoma cells, ET-1 or EGF induced rapid activation of EGFR, p42/44 mitogen activated protein kinase (MAPK), and AKT."

reach
"The results indicate that the ET A R regulates cytosolic Ca 2+ in NSCLC cells.The ability of ET-1 to cause transactivation of the EGFR was investigated using NSCLC cells."

reach
"Additionally, ET-1 can stimulate transactivation of EGFR via ET A receptors in rat cardiac fibroblasts [XREF_BIBR]."
EDN1 activates EGFR. 3 / 3
3 |

"Modified assertion"

"Besides being activated by ligand binding, the EGFR can be transactivated by a growing number of different pathways, including G-protein-coupled receptors (GPCRs), cytokine receptors, ion channels, integrins, and other RTKs.37"

"Treatment of cells with GPCR agonists such as endothelin- 1 (ET-1), thrombin, bombesin, and lysophosphatidic acid (LPA) transactivates ErbB1 (reviewed by Zwick et al. [48]). Mechanistically, the process involves rapid stimulation of metalloproteinases followed by cleavage of an ErbB1 ligand precursor, e.g., pro-HB-EGF [49], whose binding activates ErbB1 and downstream signaling pathways"